Arabinogalactan Market - Forecast(2025 - 2031)

Arabinogalactan Market Overview

Arabinogalactan Market size is forecast to reach US$267.5 million by 2031, after growing at a CAGR of 5.5% during 2025-2031. Arabinogalactan is poised for growth driven by the increasing demand for functional beverages. Arabinogalactan is a vital prebiotic ingredient that supports gut health and immunity. Its prominence in immunity-boosting formulations is also boosting market growth. Moreover, the expansion of the nutraceutical sector and the growing preference for clean-label plant-based products further drive the market.

The inclusion of arabinogalactan’s prebiotic properties in gut health products is becoming increasingly popular, as it supports the growth of beneficial gut bacteria, vital for digestive wellness. This has resulted in a higher demand for arabinogalactan in dietary supplements, functional foods and beverages aimed at enhancing gut microbiome health. Additionally, its growing use in pet nutrition is notable with arabinogalactan being added to pet foods and supplements to support digestive health in pets. According to a survey of 2,500 dog and cat owners in the UK, USA, Brazil, Germany and China, more than 90% of pet owners believe that supporting digestive health improves the likelihood of them purchasing a product, inducing Notably the demand for prebiotics is in pet food is increasing due to growing awareness of their benefits. As more pet owners recognize the importance of gut health, arabinogalactan’s role in pet nutrition is expected to continue expanding.

Market Snapshot: 

Arabinogalactan Market - Report Coverage:

The “Arabinogalactan Market Report - Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Arabinogalactan Market.

Key Takeaways

North America dominates the market

North America is the largest market for arabinogalactan due to its well-established pharmaceutical, nutraceutical and functional food industries coupled with high consumer awareness of health and wellness trends. According to IFIC’S Food and Health Survey of 1,000 Americans, 67% of respondents stated that they were familiar with probiotics and 32% respondents stated that they actively try to consume them. The region's preference for natural and plant-based products aligns with arabinogalactan's immune-boosting and prebiotic benefits, driving its adoption in dietary supplements and functional foods. Additionally, the abundance of larch trees in the U.S. and Canada ensures a steady supply of raw material, reducing production costs and fostering local manufacturing. The regulatory support for dietary supplements along with a strong focus on innovation and sustainability further enhances North America's leadership in the arabinogalactan market.

Powder form holds the largest market

The powder segment holds a significant share of the market due to its high demand in dietary supplements, pharmaceuticals, and food & beverages. Powdered arabinogalactan is easy to incorporate into various formulations, making it a versatile option for manufacturers. As a highly soluble and stable form, arabinogalactan powder is ideal for incorporation into dietary supplements, functional foods, and beverages, where it acts as a prebiotic, fiber source, and immune booster. Its lightweight nature and longer shelf life make it cost-effective and convenient for transportation and storage, further driving its demand.

Pharmaceutical & Nutraceuticals is the largest application 

Pharmaceutical and nutraceuticals represents the largest application for arabinogalactan due to its immune-boosting, prebiotic and therapeutic properties. According to the International Probiotics Association’s 2024 report, dietary supplements sales in Europe reached $13.3 billion in 2023, with selected markets accounting for 58% of the region’s value sales. Products with digestive positioning continue to be among the preferred choices in Italy and Spain, as per the. In dietary supplements, arabinogalactan is widely used to support gut health by promoting beneficial bacteria growth and enhancing overall digestive function. Its ability to stimulate the immune system makes it a key ingredient in immune-boosting formulations especially in cold and flu remedies. In pharmaceuticals, arabinogalactan is utilized as a drug delivery agent due to its solubility and biocompatibility, enabling effective formulation of medicines. The growing consumer focus on preventive healthcare and natural remedies further drives its demand, solidifying its dominance in this sector.

Rise in demand for natural and plant-based products

The rise in demand for natural and plant-based products has significantly boosted the market for arabinogalactan, a polysaccharide derived primarily from larch trees. Consumers are increasingly seeking alternatives to synthetic additives, favoring ingredients with health-promoting properties and sustainable origins. Arabinogalactan aligns perfectly with these preferences, offering benefits like immune support, gut health enhancement, and prebiotic activity. Its natural, plant-based origin makes it ideal for inclusion in clean-label foods, dietary supplements, and functional beverages. Furthermore, the global shift toward plant-based diets and environmentally friendly products has created opportunities for arabinogalactan in cosmetics and personal care, where its moisturizing and stabilizing properties are valued. This trend reflects a broader consumer preference for transparency, health, and sustainability in product choices.

Key Market Players

Arabinogalactan top 10 companies include:
1.    Archer Daniels Midland Company
2.    Cargill Incorporated
3.    Pure Encapsulations
4.    VetriScience Laboratories
5.    Thorne Research Inc.
6.    Lonza
7.    Ametis JSC
8.    FoodScience of Vermont
9.    BASF SE
10.    DuPont de Nemours Inc.

Scope of the Report: 

For more Food and Beverage Market reports, please click here